Protalix BioTherapeutics, Inc. Logo Image

Protalix BioTherapeutics, Inc.

Most Recent Annual Report

2016 Annual Report and Form 10K

Protalix BioTherapeutics, Inc.

Annual
Report

Protalix BioTherapeutics, Inc. does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

  • Protalix BioTherapeutics, Inc.

    2015 Annual Report

  • Protalix BioTherapeutics, Inc.

    2014 Annual Report

  • Protalix BioTherapeutics, Inc.

    2013 Annual Report

  • Show 1 more archive
  • Protalix BioTherapeutics, Inc.

    2012 Annual Report

About Protalix BioTherapeutics, Inc.

201-500 Employees
Based in Karmiel, Israel

Protalix BioTherapeutics, Inc., a biopharmaceutical company, through Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system in the United States.

Ticker:
PLX
Exchange:
AMEX (See More AMEX Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol